Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin. - Wikidata - awgldk - TriplyDB

Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin.

Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin.

http://www.wikidata.org/entity/Q34694922

about

Acute kidney injury: global health alert.Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: a randomized, controlled trial Computerized physician order entry: promise, perils, and experience.Systematic review of clinical decision support interventions with potential for inpatient cost reduction.Neutrophil gelatinase associated lipocalin in acute kidney injury.Acute kidney injury: Global health alert.Acute kidney injury: global health alert

P2860

Q33871939-B8FAD54D-6153-49C4-8D13-178FDBADE4B9 Q35986250-4B6E3C7F-7159-466D-AAEE-098E283E4078 Q36039089-14EAB0AA-C41B-4032-87A0-F892FE98A07D Q37406323-F5BD4E14-1870-414C-B986-9C4C4B4E96D0 Q37426469-DB1B14A0-0246-4887-B733-28CC4FCB7F8E Q38160639-9EEF3E41-AC61-40DB-BC5C-35895F94C54D Q54324308-17692006-AE20-4305-9970-00F8EE812BF2 Q58358374-5B69F221-11EA-423B-BE38-4A8E82E51B70

P2860

Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin.

http://www.wikidata.org/entity/Q34694922

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@ast

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@en

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@nl

type

label

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@ast

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@en

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@nl

prefLabel

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@ast

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@en

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@nl

P1433

Q34694922-0C1EDBD6-EDA7-48C5-A101-DD75D1824317

P1476

Q34694922-831E29A6-4CEE-44D4-AC99-BE3AF9A6EE83

P2093

Q34694922-070B70C7-2CE7-45C5-9CD0-0228A7381CD5

Q34694922-1F0A9787-0BF7-4923-9654-4EB1F86DBEBE

Q34694922-3552BA17-5E89-415F-9BCE-E6DAD5728DE8

Q34694922-811D7FD7-D456-4089-9EEE-888882DA3EB9

Q34694922-F7B6235E-89F0-437C-B0B4-CEAEF97EC61A

P2860

Q34694922-01EDB436-5D7F-426D-A252-9C79E0565C63

Q34694922-03945211-7CBC-4A64-A059-79AA35EB2A66

Q34694922-07F47702-0FCA-437A-B85E-68EF00C13CA9

Q34694922-1A62B51B-FE8B-4573-8C61-5B1E62FDBFE0

Q34694922-250EEFAF-8ED2-404A-BD89-A38AC96AB75D

Q34694922-27C53B07-FBA1-4270-84DF-5C394D0F741B

Q34694922-2B31A15C-008B-47C5-A3B0-770EBBF28552

Q34694922-2C3F94BD-2A5C-461A-8098-2E07205D3028

Q34694922-37EF6427-2CC7-4C30-971D-86F1C9D05215

Q34694922-51FCE9A8-5B4B-457D-A347-AF614D75BE18

P304

Q34694922-D6872394-8F29-402F-B424-51AC56A6A20F

P31

Q34694922-DB394235-B149-4502-BA2E-7CA4D359ECFE

P356

Q34694922-D5CAF4A4-4F8E-44E6-9943-77B82F6DA64D

P433

Q34694922-A67FBECE-E098-4763-89C4-0309D882AAC9

P478

Q34694922-A35C2048-ECEC-47E8-ACC1-7DBE1D629D24

P577

Q34694922-B4AF363E-EBC8-4364-892B-CD7F011CF0B8

P5875

Q34694922-D5BCAFAB-B5D8-4649-9928-B56102F7463E

P698

Q34694922-67E61F03-CD12-47F1-A433-A0E9EA2E0BE0

P932

Q34694922-35F8F2D2-FF5D-44A0-B026-2211EADC107D

P356

P1433

American Journal of Health-System Pharmacy

P1476

Effects of clinical decision s ...... ng of tobramycin and amikacin.

@en

P2093

Cori L Nelsen

http://www.w3.org/2001/XMLSchema#string

Jacob A McCoy

http://www.w3.org/2001/XMLSchema#string

Josh F Peterson

http://www.w3.org/2001/XMLSchema#string

Lemuel R Waitman

http://www.w3.org/2001/XMLSchema#string

Zachary L Cox

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Role of computerized physician order entry systems in facilitating medication errors

Prediction of creatinine clearance from serum creatinine

Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review.

Computer support for determining drug dose: systematic review and meta-analysis.

Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations.

Impact of computerized physician order entry on clinical practice in a newborn intensive care unit.

Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia.

P304

624-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2146/AJHP100155

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50409373

http://www.w3.org/2001/XMLSchema#string

P698

21411805

http://www.w3.org/2001/XMLSchema#string

P932

3060379

http://www.w3.org/2001/XMLSchema#string